Prognostic factors in adult patients hospitalized for pneumonia caused by Legionella pneumophila;Factores pronósticos en adultos hospitalizados por neumonía causada por Legionella pneumophila

Revista Chilena de Infectologia

Volumn 32, Issue 4, 2015, Pages 435-444

  Regueiro Mira, María Virtudes ^a   Pita Fernández, Salvador ^b   Pértega Díaz, Sonia ^b   López Calviño, Beatriz ^b   Seoane Pillado, Teresa ^b   Fernández Albalat Ruiz, María ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Comorbidity; Inhospital mortality; Intensive care unit; Lactate dehydrogenase; Legionella pneumophila

Indexed keywords

CREATININE; LACTATE DEHYDROGENASE;

ADULT; AGE; AGED; BACTERIAL PNEUMONIA; BLOOD; COMORBIDITY; DELIRIUM; DYSPNEA; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LIVER DISEASES; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SEASON; SPAIN; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; AGED; COMORBIDITY; CREATININE; DELIRIUM; DYSPNEA; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; L-LACTATE DEHYDROGENASE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LIVER DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROGNOSIS; RETROSPECTIVE STUDIES; SEASONS; SPAIN;

EID: 84943419988     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182015000500010     Document Type: Article

References (39)

1. Beauté J, Zucs P, de Jong B. Legionnaires disease in Europe, 2009-2010. European Legionnaires`Disease Surveillance Network 2013; 18 (20417).
2. Jespersen S, Sogaard O, Schonheyder H, Fine M, Ostergaad L. Clinical features and predictors of mortality in admitted patients with community and hospital-acquired legionellosis: A Danish historical cohort study. BMC Infect Dis 2010; 10: 124.
3. Ulloa M. Legionella pneumophila. Rev Chilena Infectol 2008; 25 (5): 208.
4. García-Fulgueiras A, Navarro C, Fenoll D, García J, González-Diego P, Jiménez-Buñuales T, et al. Legionnaires`disease outbreak in Murcia, Spain. Emerg Infect Dis 2003; 9 (8): 915-21.
5. Díaz A, Barría P, Niederman M, Restrepo M, Dreyse J, Fuentes G, et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile. The increasing prevalence of respiratory viruses among classic pathogens. CHEST 2007; 131: 779-87.
6. Arnold F, Summersgill J, La Joie A, Peyrani P, Marrie T, Rossi P, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175: 1086-93.
7. Arancibia F, Cortés C, Valdés M, Cerda J, Hernández A, Soto L, et al. Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile. CHEST 2014; 145: 290-6.
8. I Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, et al. Normativa para el diagnóstico y el tratamiento de laneumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Arch Bronconeumol 2005; 41 (5): 272-89.
9. Torres A, Caylà J A. Diagnostic testing and careful investigation of cases are needed to control unsuspected Legionnaires´disease outbreaks. Arch Bronconeumol 2002; 38 (1): 1-3.
10. Daumas A, El-Mekaoui F, Bataille S, Caporossi L. Acute tubulointersticial nephritis complicating Legionnaires disease: a case report. J Med Case Rep [Internet] 2012; 6 (1): [100 p.].
11. Red Nacional de Vigilancia Epidemiológica. Centro Nacional de Epidemiología. Legionelosis. Situación general y evolución de la enfermedad en España. Datos de la Red Nacional de Vigilancia Epidemiológica. Datos actualizados en noviembre de 2010. Instituto de Salud Carlos 3; 2010.
12. Viasus D, Di Yacovo S, García-Vidal C, Verdaguer R, Manresa F, Dorca J, et al. Community-acquired Legionella pneumophila pneumonia. A single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine 2013; 92 (1): 51-60.
13. Benito J, Montejo J, Cancelo L, Zalacaín R, López L, Fernández Gil de Pareja J, et al. Neumonía comunitaria por Legionella pneumophila serogrupo 1: 97 casos 2003; 21(8): 394-400.
14. Pedro-Botet M, Sabria-Leal M, Haro M, Rubio C, Giménez G, Sopena N, et al. Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. Eur Respir J 1995; 8: 1929-33.
15. Sopena N, Force L, Pedro-Botet M, Barrufet P, Sauca G, García-Núñez M, et al. Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 2007; 29: 138-42.
16. Gudiol C, García-Vidal C, Fernández-Sabé N, Verdaguer R, Lladó L, Roca J, et al. Clinical features and outcomes of Legionnaires disease in solid organ transplant recipients. Transpl Infect Dis 2009; 11: 78-82.
17. El-Ebiary M, Sarmiento X, Torres A, Nogué S, Mesalles E, Bodí M, et al. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am J Respir Crit Med 1997; 156: 1467-72.
18. Haeuptle J, Zaborsky R, Fiumefreddo R, Trampuz A, Steffen I, Frei R, et al. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28: 55-60.
19. Gacouin A, Le Tulzo Y, Lavoue S, Camus C, Hoff J, Bassen R, et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med 2002; 28: 686-91.
20. Howden B, Stuart R, Tallis G, Bailey M, Johnson P. Treatment and outcome of 104 hospitalized patients with legionnaires disease. Intern Med J 2003; 33: 484-8.
21. Formica N, Yates M, Beers M, Carnie J, Hogg G, Ryan N, et al. The impact of diagnosis by legionella urinary antigen test on the epidemiology and outcomes of Legionnaires´disease. Epidemiol Infect 2001; 127: 275-80.
22. Sopena N, Pedro-Botet L, Mateu L, Tolschinsky G, Rey-Joly C, Sabriá M. Community-acquired Legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc 2007; 55: 114-9.
23. Molinos L. Detección de antígenos en la orina. Arch Bronconeumol 2006; 42 (3):101-3.
24. Charlson M, Pompei P, Ales K, MacKenzie C. Experiencia Clínica A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373-83.
25. Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145 (4): 24-54.
26. Lettinga K, Verbon A, Weverling G, Schellekens J, Den Boer J, Yzerman E. Legionnaires disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis 2002; 8 (12): 1448-54.
27. Díaz A, Álvarez M, Callejas C, Rosso R, Schnettler K, Saldías F. Clinical picture and prognostic factors for severe community acquired pneumonia in adults admitted to the intensive care unit. Arch Bronconeumol 2005; 41 (1): 20-6.
28. Saldías F, Mardóñez J, Marchesse M, Viviani P, Farías G, Díaz A, et al. Neumonía adquirida en la comunidad en pacientes adultos hospitalizados. Presentación clínica y pronósticos. Rev Med Chile 2002; 130 (12): 1373-82.
29. Van Arsdall J, Wunderlich H, Melo J, Nagar D, Ferris F, Raff M. The protean manifestations of Legionnaires`disease. J Infect 1983; 7 (1): 51-62.
30. Agulló-Ortuño M, García-Mancebo M, Montes-Ares O, Noguera-Velasco J. Biochemical and immunologic features of an outbreak of Legionnaires disease: comparative study between community-acquired pneumonias. Diagn Microbiol Infect Dis 2006; 56: 7-11.
31. Fiumefreddo R, Zaborsky R, Haeuptle J, Christ-Crain M, Trampuz A, Steffen I, et al. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med 2009; 9 (4). doi: 10.1186/1471-2466-9-4.
32. Ríos F, Estenssoro E, Villarejo F, Valentini R, Aguilar L, Pezzola D, et al. Lung function and organ dysfunctions in 178 patients requiring mechanical ventilation during the 2009 influenza A (H1N1) pandemic. Critical Care 2011; 15 (4): R201. doi: 10.1186/cc10369.
33. Falcó V. Legionella pneumophila. A cause of severe community-acquired pneumonia. CHEST 1991; 100 (4): 1007-11.
34. Falcó V, Molina I, Juste C, Crespo M, Almirante B, Pigrau C, et al. Tratamiento de la neumonía por Legionella pneumophila. ¿Macrólidos o quinolonas? Enferm Infecc Microbiol Clin 2006; 24 (6): 360-4.
35. Zager R, Johnson A, Becker K. Renal cortical lactate dehydrogenase: a useful, accurate, quantitative marker of in vivo tubular injury and acute renal failure 2013; PLoS One 2013; 8 (6): e66776.
36. Rello J, Gattarelo S, Souto J, Sole-Violan J, Valles J, Peredo R. Community-acquired Legionella pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy. Med Intensiva 2013; 37 (5): 320-6.
37. Chidiac C, Che D, Pires-Cronenburger S, Jarraud S, Campese C, Bissery A, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J 2012; 39: 963-70.
38. Domínguez A, Álvarez J, Sabria M, Carmona G, Torner N, Oviedo M. Factors influencing the case-fatality rate of Legionnaires disease. Int J Tuberc Lung Dis 2009; 13 (3): 407-12.
39. Tkatch L, Kusne S, Irish W, Krystofiak S, Wing E. Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a Tertiary Care Center. Clin Infect Dis 1998; 27: 1479-86.